A phase II open-label multicentre study of the efficacy of ZD1839 (Iressa (TM)) in combination with irradiation followed by chemotherapy in patients with inoperable stage III non small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2015
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer
- 18 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 24 Mar 2006 New trial record.